Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours.

[1]  Kenneth G. Thurston,et al.  Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. , 2006, Journal of vascular and interventional radiology : JVIR.

[2]  J. Thie,et al.  Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma. , 2006, Cancer biotherapy & radiopharmaceuticals.

[3]  Kenneth G. Thurston,et al.  Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. , 2006, Journal of vascular and interventional radiology : JVIR.

[4]  Robert J. Lewandowski,et al.  Treatment of Unresectable Primary and Metastatic Liver Cancer with Yttrium-90 Microspheres (TheraSphere®): Assessment of Hepatic Arterial Embolization , 2006, CardioVascular and Interventional Radiology.

[5]  Kenneth G. Thurston,et al.  Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. , 2005, Journal of vascular and interventional radiology : JVIR.

[6]  Kenneth G. Thurston,et al.  90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. , 2005, Journal of vascular and interventional radiology : JVIR.

[7]  N. Habib,et al.  Portal hypertension secondary to 90Yttrium microspheres: an unknown complication. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Salem,et al.  Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging. , 2005, Journal of vascular and interventional radiology : JVIR.

[9]  T. Helmberger,et al.  Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors. , 2005, Cancer biotherapy & radiopharmaceuticals.

[10]  L. Dawson.  Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma. , 2005, Journal of vascular and interventional radiology : JVIR.

[11]  J. Dancey,et al.  Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. , 2005, Journal of vascular and interventional radiology : JVIR.

[12]  A. Li,et al.  Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer , 1997, European Journal of Nuclear Medicine.

[13]  N. Avril,et al.  90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  G. van Hazel,et al.  Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer , 2004, Journal of surgical oncology.

[15]  M. Thirlwell,et al.  Radioembolization for hepatic metastases. , 2002, Seminars in oncology.

[16]  V. Gebski,et al.  Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  R. Cannan,et al.  Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases , 2001, Journal of Gastrointestinal Surgery.

[18]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[19]  W. Ensminger,et al.  Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  L. Feinendegen.  Microdosimetric considerations of hepatic radioembolization. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  G. van Hazel,et al.  Regression of liver metastases following treatment with yttrium-90 microspheres. , 2010, The Australian and New Zealand journal of surgery.